Literature DB >> 33011844

D-allulose provides cardioprotective effect by attenuating cardiac mitochondrial dysfunction in obesity-induced insulin-resistant rats.

Wanpitak Pongkan1,2, Kewarin Jinawong1,3,4, Wasana Pratchayasakul1,3,4, Thidarat Jaiwongkam1,3,4, Sasiwan Kerdphoo1,3,4, Masaaki Tokuda5, Siriporn C Chattipakorn1,3,4, Nipon Chattipakorn6,7,8.   

Abstract

PURPOSE: Obesity-induced insulin resistant is associated with cardiovascular diseases via impairing cardiac mitochondria. Recently, D-allulose could protect β-islets and improve insulin resistance. However, the effects of D-allulose on the heart and cardiac mitochondrial function under obesity-induced insulin-resistant condition has not been investigated. In this study, we aimed to investigate the effects of D-allulose on metabolic parameters, cardiac function, heart rate variability (HRV), cardiac mitochondrial function, and apoptosis in the heart of obesity-induced insulin-resistant rats induced by chronic high fat diet consumption.
METHODS: Male Wistar rats (n = 24) received a normal fat diet (ND) or high fat diet (HFD) for 12 weeks. Then, HFD group was randomly divided into three subgroups to receive (1) HFD with distilled water, (2) HFD with 3% D-allulose 1.9 g/ kg·BW/ day (HFR), and (3) HFD with metformin 300 mg/kg·BW/ day (HFM) by diluted in drinking water daily for 12 weeks. At week 24, proposed study parameters were investigated.
RESULTS: Chronic HFD consumption induced obesity-induced insulin resistant in rats and high fat diet impaired cardiac function and HRV. HFR rats had improved insulin sensitivity as indicated by decreasing HOMA index, plasma insulin, whereas HFM decreased body weight, visceral fat, plasma cholesterol, and plasma LDL. HFR and HFM provided similar efficacy in improving HRV and attenuating cardiac mitochondrial dysfunction, leading to improved cardiac function.
CONCLUSIONS: Even though this is the first investigation of the D-allulose impact on the heart with a relatively small sample size, it clearly demonstrated a beneficial effect on the heart. D-allulose exerted a therapeutic effect on metabolic parameters except for body weight and lipid profiles and provided cardioprotective effects similar to metformin via attenuating cardiac mitochondrial function in obesity-induced insulin-resistant rats.

Entities:  

Keywords:  Cardiovascular health; D-allulose; Diet-induced insulin resistance; Metformin; Rat model

Year:  2020        PMID: 33011844     DOI: 10.1007/s00394-020-02394-y

Source DB:  PubMed          Journal:  Eur J Nutr        ISSN: 1436-6207            Impact factor:   5.614


  41 in total

Review 1.  Mechanisms of Insulin Action and Insulin Resistance.

Authors:  Max C Petersen; Gerald I Shulman
Journal:  Physiol Rev       Date:  2018-10-01       Impact factor: 37.312

Review 2.  Link between Metabolic Syndrome and Insulin Resistance.

Authors:  Zoran Gluvic; Bozidarka Zaric; Ivana Resanovic; Milan Obradovic; Aleksandar Mitrovic; Djordje Radak; Esma R Isenovic
Journal:  Curr Vasc Pharmacol       Date:  2017       Impact factor: 2.719

3.  Insulin and insulin resistance.

Authors:  Gisela Wilcox
Journal:  Clin Biochem Rev       Date:  2005-05

Review 4.  The role of mitochondrial dysfunction in cardiovascular disease: a brief review.

Authors:  Dimitry A Chistiakov; Tatiana P Shkurat; Alexandra A Melnichenko; Andrey V Grechko; Alexander N Orekhov
Journal:  Ann Med       Date:  2017-12-18       Impact factor: 4.709

Review 5.  The Definition and Prevalence of Obesity and Metabolic Syndrome.

Authors:  Atilla Engin
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

Review 6.  Mechanisms linking obesity to insulin resistance and type 2 diabetes.

Authors:  Steven E Kahn; Rebecca L Hull; Kristina M Utzschneider
Journal:  Nature       Date:  2006-12-14       Impact factor: 49.962

Review 7.  Cardiac dysfunction and oxidative stress in the metabolic syndrome: an update on antioxidant therapies.

Authors:  Olesya Ilkun; Sihem Boudina
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

Review 8.  Type 2 diabetes mellitus.

Authors:  Ralph A DeFronzo; Ele Ferrannini; Leif Groop; Robert R Henry; William H Herman; Jens Juul Holst; Frank B Hu; C Ronald Kahn; Itamar Raz; Gerald I Shulman; Donald C Simonson; Marcia A Testa; Ram Weiss
Journal:  Nat Rev Dis Primers       Date:  2015-07-23       Impact factor: 52.329

9.  Testosterone deprivation accelerates cardiac dysfunction in obese male rats.

Authors:  Wanpitak Pongkan; Hiranya Pintana; Sivaporn Sivasinprasasn; Thidarat Jaiwongkam; Siriporn C Chattipakorn; Nipon Chattipakorn
Journal:  J Endocrinol       Date:  2016-03-21       Impact factor: 4.286

Review 10.  Diabetes, cardiovascular disease and the microcirculation.

Authors:  W David Strain; P M Paldánius
Journal:  Cardiovasc Diabetol       Date:  2018-04-18       Impact factor: 9.951

View more
  2 in total

1.  Polyunsaturated Fatty Acid EAB-277® Supplementation Improved Heart Rate Variability and Clinical Signs in Tracheal Collapse Dogs.

Authors:  Raktham Mektrirat; Thareerat Rueangsri; Waraporn Keeratichandacha; Sasiwimon Soonsawat; Chavalit Boonyapakorn; Wanpitak Pongkan
Journal:  Front Vet Sci       Date:  2022-07-14

2.  Rare sugars: metabolic impacts and mechanisms of action: a scoping review.

Authors:  Alison Smith; Amanda Avery; Rebecca Ford; Qian Yang; Aurélie Goux; Indraneil Mukherjee; David C A Neville; Preeti Jethwa
Journal:  Br J Nutr       Date:  2021-09-10       Impact factor: 4.125

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.